Abstract
Academic bullying is a pervasive and longstanding issue that negatively affects all fields of science. While influential factors such as scientific discipline, sex, and ethnicity have been investigated, the impact of perpetrators’ age on the contextual behaviors of academic bullying has not been thoroughly studied. Our cross-sectional global survey of academic bullying, involving 2,390 participants, provides evidence that age significantly influences the contextual behaviors of academic bullying. Our results revealed that the youngest perpetrators (aged 25-35) exhibit significantly less abusive behavior compared to other age categories (36 and older). Additionally, the lowest percentage of abusive behavior was observed in the youngest group, while the highest was found in the older groups (aged 56-65). Our comprehensive analysis on the potential influence of the perpetrator’s academic position, ethnicity, or sex on their age group revealed no significant impact. These findings have strong implications for the development of more customized academic bullying training, policy development, and monitoring strategies, ultimately benefiting the scientific community at large in many aspects including evolution of science and improving the mental health of the academic workforce.
Competing Interest Statement
Sherry Moss and Morteza Mahmoudi are directors of the Academic Parity Movement (www.paritymovement.org), a non-profit organization dedicated to addressing academic discrimination, violence and incivility. MM is a co-founder of Targets' Tip, and he receives royalties/honoraria for his published books, plenary lectures, and licensed patent.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In this study, we analyzed data from our cross-sectional global survey on the topic. Full details about IRB approval [Wake Forest University (IRB00023594) and Michigan State University (STUDY00003215)], consent, and the declaration of informed consent for data usage are provided in the survey documentation.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
